Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Liraglutide Market Report 2025

Liraglutide Global Market Report 2025 – By Brands (Victoza, Saxenda), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies), By Type Of Application (Diabetes Treatment, Weight Management), By End-Users (Hospitals And Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2025-2034

Liraglutide Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Liraglutide Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Liraglutide Market Definition

Liraglutide is a GLP-1 receptor agonist used to manage type 2 diabetes and obesity. It helps lower blood sugar levels and promotes weight loss by mimicking the incretin hormone GLP-1. Administered via subcutaneous injection, IT enhances insulin secretion and reduces appetite. Liraglutide is marketed under the brand names Victoza for diabetes and Saxenda for obesity.

The main liraglutide brands are victoza and saxenda. Victoza is a brand name for liraglutide, a medication used to treat type 2 diabetes. It can be distributed through hospital pharmacies, retail pharmacies, drug stores, and online pharmacies, and IT is used for diabetes treatment and weight management. It is used by various end-users, including hospitals, clinics, and home care settings.

Liraglutide Market Segmentation

The liraglutide market covered in this report is segmented –

1) By Brands: Victoza, Saxenda

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies

3) By Type Of Application: Diabetes Treatment, Weight Management

4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:

1) By Victoza: Type 2 Diabetes Treatment Or Weight Management

2) By Saxenda: Weight Loss Treatment Or Obesity Management

Liraglutide Market Size and growth rate 2025 to 2029: Graph

Liraglutide Market Size 2025 And Growth Rate

The liraglutide market size has grown strongly in recent years. It will grow from $6.38 billion in 2024 to $6.95 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the increasing number of people diagnosed with type 2 diabetes, growing obesity rates, extensive clinical trials, growing awareness of diabetes complications, and rising innovations in drug delivery systems.

Liraglutide Market Growth Forecast

The liraglutide market size is expected to see strong growth in the next few years. It will grow to $9.66 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing insurance and reimbursement policies, healthcare infrastructure development, increasing awareness and educational initiatives, a growing aging population, and the increasing prevalence of diabetes. Major trends in the forecast period include the use of artificial intelligence and machine learning, demand for wearable technology, continuous glucose monitoring integration, biotechnology advancements, and the development of digital health platforms.

Book your 30 minutes free consultation with our research experts

Contact Us

Liraglutide Market Driver: Impact Of Diabetic Population Growth On The Liraglutide Market

The increasing diabetic population is expected to propel the growth of the liraglutide market going forward. Diabetes is a chronic condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or ineffective insulin use. The incidence of diabetes is increasing due to factors such as sedentary lifestyles, unhealthy diets, and rising obesity rates worldwide. Diabetes drugs such as liraglutide help by mimicking the action of the hormone GLP-1, which enhances insulin secretion, lowers blood sugar levels, and promotes weight loss, thereby aiding in the management of type 2 diabetes.For instance, in March 2024, according to a report by the Government of the United Kingdom, a UK-based information website, In March 2023, the proportion of people with type 1 diabetes in England receiving all 8 care processes at GP practices involved in the NDA increased to 43.8%, compared to 35.2% the year before. Therefore, the increasing diabetic population is driving the growth of the liraglutide market.

Global Liraglutide Market Major Players

Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

Global Liraglutide Market Trend: Expansion Of Generic GLP-1 Products In The Liraglutide Market

Major companies operating in the liraglutide market are developing novel products, such as generic GLP-1, to expand treatment options and address market demand for more affordable alternatives. Generic GLP-1 refers to versions of GLP-1 receptor agonists that are produced after the expiration of patent protection on the original branded medications, offering cost-effective alternatives for treating conditions like type 2 diabetes and obesity. For instance, in June 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, introduced the first generic GLP-1, similar to Victoza, in the U.S. market, meeting the rising demand for these therapies. Liraglutide injections are prescribed to enhance blood sugar management in adults and children aged 10 and above with type 2 diabetes and to lower the risk of cardiovascular incidents in adults with type 2 diabetes and existing cardiovascular conditions.

Liraglutide Market Merger And Acquisition: Biocon Limited And Juno Pharmaceuticals Partner To Commercialize Liraglutide In Canada

In October 2023, Biocon Limited, an India-based biopharmaceutical company, partnered with Juno Pharmaceuticals to commercialize its vertically integrated, complex formulation, Liraglutide. Under the terms of this partnership agreement, Biocon will be responsible for obtaining regulatory approval for Liraglutide and, thereafter, for the manufacture and supply of the product in the Canadian market. Juno Pharmaceuticals is a Canada-based pharmaceutical company that focuses on bringing complex and high-value generic and biosimilar products to the market.

Regional Outlook For The Global Liraglutide Market

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the liraglutide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Liraglutide Market?

The liraglutide market consists of sales of insulin products, weight management supplements, nutritional supplements, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Liraglutide Industry?

The liraglutide market research report is one of a series of new reports from The Business Research Company that provides liraglutide market statistics, including liraglutide industry global market size, regional shares, competitors with a liraglutide market share, detailed liraglutide market segments, market trends and opportunities, and any further data you may need to thrive in the liraglutide industry. This liraglutide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Liraglutide Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $6.95 billion
Revenue Forecast In 2034 $9.66 billion
Growth Rate CAGR of 8.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings Subsegments: 1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Liraglutide Market Characteristics

    3. Liraglutide Market Trends And Strategies

    4. Liraglutide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Liraglutide Growth Analysis And Strategic Analysis Framework

    5.1. Global Liraglutide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Liraglutide Market Growth Rate Analysis

    5.4. Global Liraglutide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Liraglutide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Liraglutide Total Addressable Market (TAM)

    6. Liraglutide Market Segmentation

    6.1. Global Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Victoza

    Saxenda

    6.2. Global Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies And Drug Stores

    Online Pharmacies

    6.3. Global Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Diabetes Treatment

    Weight Management

    6.4. Global Liraglutide Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals And Clinics

    Homecare Settings

    6.5. Global Liraglutide Market, Sub-Segmentation Of Victoza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Type 2 Diabetes Treatment

    Weight Management

    6.6. Global Liraglutide Market, Sub-Segmentation Of Saxenda, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Weight Loss Treatment

    Obesity Management

    7. Liraglutide Market Regional And Country Analysis

    7.1. Global Liraglutide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Liraglutide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Liraglutide Market

    8.1. Asia-Pacific Liraglutide Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Liraglutide Market

    9.1. China Liraglutide Market Overview

    9.2. China Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Liraglutide Market

    10.1. India Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Liraglutide Market

    11.1. Japan Liraglutide Market Overview

    11.2. Japan Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Liraglutide Market

    12.1. Australia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Liraglutide Market

    13.1. Indonesia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Liraglutide Market

    14.1. South Korea Liraglutide Market Overview

    14.2. South Korea Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Liraglutide Market

    15.1. Western Europe Liraglutide Market Overview

    15.2. Western Europe Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Liraglutide Market

    16.1. UK Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Liraglutide Market

    17.1. Germany Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Liraglutide Market

    18.1. France Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Liraglutide Market

    19.1. Italy Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Liraglutide Market

    20.1. Spain Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Liraglutide Market

    21.1. Eastern Europe Liraglutide Market Overview

    21.2. Eastern Europe Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Liraglutide Market

    22.1. Russia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Liraglutide Market

    23.1. North America Liraglutide Market Overview

    23.2. North America Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Liraglutide Market

    24.1. USA Liraglutide Market Overview

    24.2. USA Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Liraglutide Market

    25.1. Canada Liraglutide Market Overview

    25.2. Canada Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Liraglutide Market

    26.1. South America Liraglutide Market Overview

    26.2. South America Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Liraglutide Market

    27.1. Brazil Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Liraglutide Market

    28.1. Middle East Liraglutide Market Overview

    28.2. Middle East Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Liraglutide Market

    29.1. Africa Liraglutide Market Overview

    29.2. Africa Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Liraglutide Market Competitive Landscape And Company Profiles

    30.1. Liraglutide Market Competitive Landscape

    30.2. Liraglutide Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

    31. Liraglutide Market Other Major And Innovative Companies

    31.1. Bristol-Myers Squibb Company

    31.2. AstraZeneca PLC

    31.3. Novartis International AG

    31.4. Takeda Pharmaceutical Company Limited

    31.5. GlaxoSmithKline Plc

    31.6. Eli Lilly and Company

    31.7. Amgen Inc.

    31.8. Boehringer Ingelheim International GmbH

    31.9. Novo Nordisk A/S

    31.10. Teva Pharmaceutical Industries Ltd.

    31.11. Cipla Limited

    31.12. Dr. Reddy's Laboratories Ltd.

    31.13. Biocon Limited

    31.14. Hanmi Pharmaceutical Co. Ltd.

    31.15. Intarcia Therapeutics Inc.

    32. Global Liraglutide Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Liraglutide Market

    34. Recent Developments In The Liraglutide Market

    35. Liraglutide Market High Potential Countries, Segments and Strategies

    35.1 Liraglutide Market In 2029 - Countries Offering Most New Opportunities

    35.2 Liraglutide Market In 2029 - Segments Offering Most New Opportunities

    35.3 Liraglutide Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Liraglutide Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Liraglutide Market, Sub-Segmentation Of Victoza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Liraglutide Market, Sub-Segmentation Of Saxenda, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Liraglutide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Liraglutide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Roche Holding AG Financial Performance
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Sanofi S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Liraglutide Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Liraglutide Market, Sub-Segmentation Of Victoza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Liraglutide Market, Sub-Segmentation Of Saxenda, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Liraglutide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Liraglutide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Roche Holding AG Financial Performance
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Sanofi S.A. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Read More

Antidiarrheals Global Market Report 2025 – By Drug Class (Mucosal Protectants, Motility Modifying Drugs), By Application (Adults, Childrens), By Type (OTC drugs, Prescription Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Aging Global Market Report 2025 – By Product Type (UV Absorbers, Anti-Wrinkle Products, Dermal Fillers, Botox, Anti-Stretch Mark Products), By Treatment (Hair Restoration, Adult Acne Therapy, Breast Augmentation, Liposuction, Chemical Peel, Other Treatments), By Demographic (Generation X, Baby Boomers, Generation Y, Generation Z), By Application (Anti-Wrinkle Treatment, Anti-Pigmentation, Skin Resurfacing, Other Applications), By End-User (Hospitals, Clinics, Home Healthcare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anticoagulants Global Market Report 2025 – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagulant), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications), By End User (Hospitals, Homecare, Specialty Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biomarkers Global Market Report 2025 – By Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Disease (Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases), By Type (Biomarker Of Exposure, Biomarker Of Diseases), By Audiences (Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies), By Application (Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery And Development, Drug Formulation, Forensic Application, Other Applications (DNA Fingerprinting And Others)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Botanical Supplements Global Market Report 2025 – By Source (Herbs, Leaves, Spices, Flowers, Other Sources), By Form (Powder, Liquid, Tablets, Capsules, Gummies, Other Forms), By Application (Energy And Weight Management, Bone And Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Immunotherapy Global Market Report 2025 – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma), By End User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Compression Therapy Global Market Report 2025 – By Product (Compression Pumps, Compression Stockings, Compression Bandages, Compression Tapes), By Technique (Static Compression Therapy, Dynamic Compression Therapy), By Application (Varicose Vein Treatment, Deep Vein Thrombosis Treatment, Lymphedema Treatment, Leg Ulcer Treatment, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Contraceptives Global Market Report 2025 – By Product (Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices), By Age Group (15-24 Years, 25-34 Years, 35-44 Years, 44 Years), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Liraglutide market?

Liraglutide is a GLP-1 receptor agonist used to manage type 2 diabetes and obesity. It helps lower blood sugar levels and promotes weight loss by mimicking the incretin hormone GLP-1. Administered via subcutaneous injection, it enhances insulin secretion and reduces appetite. Liraglutide is marketed under the brand names Victoza for diabetes and Saxenda for obesity. For further insights on the Liraglutide market, request a sample here

How will the Liraglutide market drivers and restraints affect the market dynamics? What forces will shape the Liraglutide industry going forward?

The Liraglutide market major growth driver - Impact Of Diabetic Population Growth On The Liraglutide Market. For further insights on the Liraglutide market, request a sample here

What is the forecast market size or the forecast market value of the Liraglutide market?

The Liraglutide market size has grown strongly in recent years. The liraglutide market size has grown strongly in recent years. It will grow from $6.38 billion in 2024 to $6.95 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the increasing number of people diagnosed with type 2 diabetes, growing obesity rates, extensive clinical trials, growing awareness of diabetes complications, and rising innovations in drug delivery systems. The liraglutide market size is expected to see strong growth in the next few years. It will grow to $9.66 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing insurance and reimbursement policies, healthcare infrastructure development, increasing awareness and educational initiatives, a growing aging population, and the increasing prevalence of diabetes. Major trends in the forecast period include the use of artificial intelligence and machine learning, demand for wearable technology, continuous glucose monitoring integration, biotechnology advancements, and the development of digital health platforms. For further insights on the Liraglutide market, request a sample here

How is the Liraglutide market segmented?

The liraglutide market covered in this report is segmented –
1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings
Subsegments:
1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management For further insights on the Liraglutide market, request a sample here

Which region has the largest share of the Liraglutide market? What are the other regions covered in the report?

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Liraglutide market, request a sample here.

Who are the major players in the Liraglutide market?

Major companies operating in the liraglutide market are developing novel products, such as generic GLP-1, to expand treatment options and address market demand for more affordable alternatives. Generic GLP-1 refers to versions of GLP-1 receptor agonists that are produced after the expiration of patent protection on the original branded medications, offering cost-effective alternatives for treating conditions like type 2 diabetes and obesity. For instance, in June 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, introduced the first generic GLP-1, similar to Victoza, in the U.S. market, meeting the rising demand for these therapies. Liraglutide injections are prescribed to enhance blood sugar management in adults and children aged 10 and above with type 2 diabetes and to lower the risk of cardiovascular incidents in adults with type 2 diabetes and existing cardiovascular conditions.. For further insights on the Liraglutide market, request a sample here.

What are the key trends in the Liraglutide market?

Major trends in the Liraglutide market include Expansion Of Generic GLP-1 Products In The Liraglutide Market. For further insights on the Liraglutide market, request a sample here.

What are the major opportunities in the Liraglutide market? What are the strategies for the Liraglutide market?

For detailed insights on the major opportunities and strategies in the Liraglutide market, request a sample here.

How does the Liraglutide market relate to the overall economy and other similar markets?

For detailed insights on Liraglutide's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Liraglutide industry?

For detailed insights on the mergers and acquisitions in the Liraglutide industry, request a sample here.

What are the key dynamics influencing the Liraglutide market growth? SWOT analysis of the Liraglutide market.

For detailed insights on the key dynamics influencing the Liraglutide market growth and SWOT analysis of the Liraglutide industry, request a sample here.